SCHEMBL352849

SCHEMBL352849

CC1CCC([O])CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5408140 1.00
SCHEMBL5407202 1.00
SCHEMBL1006982 0.87
SCHEMBL766964 0.79
SCHEMBL1007064 0.79 CYP2C9 (0.33)
SCHEMBL11469288 0.78
SCHEMBL135763 0.78
SCHEMBL598344 0.78
SCHEMBL9263434 0.78 ESR2 (0.36)
SCHEMBL4059262 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 759 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0589301-A1 Carboxynilides derivatives, process for their preparation and fungicidal compositions containing them BASF Aktiengesellschaft (DE) 1994-03-30 EP claimed
CN-118325041-A Curable composition, method for producing cured product, and cured product thereof 株式会社ADEKA 2024-07-12 CN disclosed
CN-107817650-B Latent additive and composition containing the same 株式会社艾迪科 2024-07-02 CN disclosed
EP-4389755-A1 FLUORESCENT COMPOUND AND FLUORESCENCE-LABELED BIOSUBSTANCE OBTAINED USING SAME FUJIFILM Corporation (JP) 2024-06-26 EP disclosed
CN-118185235-A Curable composition, method for producing cured product, and cured product thereof 株式会社ADEKA 2024-06-14 CN disclosed
CN-108884298-B Curable composition, method for producing cured product, and cured product thereof 株式会社ADEKA 2024-05-31 CN disclosed
CN-118084809-A Compound, latent additive, composition, cured product, method for producing cured product, and method for producing composition 株式会社艾迪科 2024-05-28 CN disclosed
US-20240110918-A1 FLUORESCENT COMPOUND AND FLUORESCENTLY LABELED BIOLOGICAL SUBSTANCE USING THE SAME FUJIFILM CORPORATION (JP) 2024-04-04 US disclosed
US-20240099128-A1 COMPOUND, HOLE TRANSPORT MATERIAL, AND PHOTOELECTRIC CONVERSION ELEMENT INCLUDING SAME HODOGAYA CHEMICAL CO., LTD. (JP) 2024-03-21 US disclosed
CN-111936532-B Compound, latent additive, composition, cured product, method for producing cured product, and method for producing composition 株式会社艾迪科 2024-03-12 CN disclosed
US-4839353-A Anti-ulcer substituted pyridine derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 1989-06-13 US disclosed
EP-0318758-A2 Multilayered electrophotographical recording material BASF Aktiengesellschaft (DE) 1989-06-07 EP disclosed
EP-0280951-A1 Amino-propanol derivatives, process for their preparation and medicines containing these compounds, as well as intermediates Roche Diagnostics GmbH (DE) 1988-09-07 EP disclosed
EP-0264883-A2 Substituted pyridine derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 1988-04-27 EP disclosed
EP-0200915-A1 Aminopropanol derivatives, process for their preparation, their use and medicines containing them Roche Diagnostics GmbH (DE) 1986-11-12 EP disclosed
EP-0004532-B1 1-ARYLOXY-3-NITRATOALKYLAMINO-2-PROPANOLS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS MERCK PATENT GmbH (DE) 1981-10-14 EP disclosed
US-4288452-A 1-Aryloxy-3-nitratoalkylamino-2-propanols and use as β-receptor blocker MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1981-09-08 US disclosed
EP-0004532-A1 1-Aryloxy-3-nitratoalkylamino-2-propanols, process for their preparation and pharmaceutical compositions MERCK PATENT GmbH (DE) 1979-10-17 EP disclosed
US-3997581-A BONDING AGENTS IN SULFUR VULCANIZABLE RUBBERS DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) 1976-12-14 US disclosed
US-3936479-A 2-BENZAMIDO-BENZOPHENONES, UV STABILIZERS, PLASTICS SANDOZ LTD., (SANDOZ AG) (CH) 1976-02-03 US disclosed